Serenus Biotherapeutics to Launch Xenex UV Disinfection Robot at IPNET-K Conference 2015 in Naivasha, Kenya

Presentation will include new clinical trial data on the use of the technology to combat the spread of Ebola NAIVASHA, KENYA—NOVEMBER 16—Serenus Biotherapeutics, which is bridging the divide between the world’s leading healthcare markets and the growing demand for access to innovative drugs and devices in the emerging nations of Africa, today said it will […]

Serenus Biotherapeutics Partners With Xenex to Bring Xenex Disinfection Robots to Africa

Serenus Biotherapeutics (“Serenus”), which is bridging the divide between the world’s leading healthcare markets and the growing demand for access to innovative drugs and devices in the emerging nations of Africa, today said it had entered into an agreement with Xenex Disinfection Services to bring the Xenex pulsed xenon Full-Spectrum™ ultraviolet (UV) room disinfection system to Africa.

Serenus Biotherapeutics Names Renowned Industry Leader Skhumbuzo Ngozwana, M.D., as President

Appointment comes as company makes other key hires, expands sales staff Dublin and Johannesburg—July 8, 2015—Serenus Biotherapeutics, Inc. today named Skhumbuzo Ngozwana, M.D., an internationally recognized pharmaceutical development expert, as President of the company. Dr. Ngozwana has worked as a strategic advisor to Serenus since shortly after its founding in 2014. He brings to Serenus […]

Former Elan CEO Takes Helm of Expanded Serenus Biotherapeutics Board of Directors

New Directors Begin Tenure as Financing Totaling $18 Million Completed SAN FRANCISCO, CA and JOHANNESBURG, SOUTH AFRICA—June 11, 2015)—Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Africa, announced G. Kelly Martin, director of […]

Serenus Biotherapeutics Enters Equity Purchase and Acquisition Agreement with Ireland-based Global Life Sciences Company

SAN FRANCISCO AND JOHANNESBURG—MARCH 3, 2015—Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Africa, today announced it had secured investment of up to $43 million from Malin Corporation plc, an Ireland-based global life sciences company focused on healthcare.

Serenus Names Accomplished Group of Researchers to Scientific Advisory Board

SAN FRANCISCO AND JOHANNESBERG—OCTOBER 28, 2014—Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Sub-Saharan Africa, today announced appointment of a group of accomplished researchers to its newly established Scientific Advisory Board. “These appointments […]

Serenus Biotherapeutics Strengthens Leadership with Appointments to Board and Management

Serenus Biotherapeutics Strengthens Leadership with Appointments to Board and Management Company adds team members with extensive knowledge of Sub-Saharan African markets and global biopharmaceutical industry San Francisco and Johannesburg—July 24, 2014—Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies […]